HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wright, C. D. Articles by Brown, J. W. Search for Related Content PubMed PubMed Citation Articles by Wright, C. D. Articles by Brown, J. W.

The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 210-217, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Primary mediastinal nonseminomatous germ cell tumors. Results of a multimodality approach

CD Wright, KA Kesler, CR Nichols, Y Mahomed, LH Einhorn, ME Miller and JW Brown
Department of Surgery, Indiana University School of Medicine, Indianapolis 46223.

Before cisplatin-based chemotherapy, long-term survival after resection of primary mediastinal nonseminomatous germ cell tumors was unusual. We reviewed the case histories of 48 patients who underwent multimodality treatment for mediastinal nonseminomatous germ cell tumor between 1976 and 1988. Twenty-eight patients received initial therapy at Indiana University and 20 were referred after having had unsuccessful initial therapy elsewhere. In 44 patients (92%) the levels of either one or both serum tumor markers were elevated at the time of diagnosis. Five patients had choriocarcinoma, three embryonal carcinoma, 12 yolk sac carcinoma, four teratocarcinoma, 22 mixed cell type, and two had an unclassified type. Twenty-two of the 28 patients in our initial therapy group had a complete response to treatment, as defined by normal serum tumor markers and absence of residual tumor. In this group, 16 patients had resection of residual disease after chemotherapy, four had total or near total resection before chemotherapy, and only two had chemotherapy alone. Seventeen patients are surviving after this treatment with a median survival of 64 months and a 57% 5-year Kaplan-Meier survival rate. Only two of the 20 patients who were referred for salvage chemotherapy had a complete response. Both required resection of residual disease after salvage chemotherapy. Only one patient survived after this treatment. There was no significant treatment morbidity or mortality. A multimodality approach to primary mediastinal nonseminomatous germ cell tumor with intensive cisplatin-based chemotherapy, emphasis on normalizing serum tumor markers, and aggressive resection of residual disease now offers survival to a significant number of patients.

This article has been cited by other articles:

				K. Asakura, Y. Izumi, T. Ikeda, Y. Kimura, H. Horinouchi, Y. Hayashi, and H. Nomori Mediastinal Germ Cell Tumor With Somatic-Type Malignancy: Report of 5 Stage I/II Cases Ann. Thorac. Surg., September 1, 2010; 90(3): 1014 - 1016. [Abstract] [Full Text] [PDF]

				S. M. Radaideh, V. C. Cook, K. A. Kesler, and L. H. Einhorn Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy Ann. Onc., April 1, 2010; 21(4): 804 - 807. [Abstract] [Full Text] [PDF]

				H. Sakurai, H. Asamura, K. Suzuki, S.-i. Watanabe, and R. Tsuchiya Management of Primary Malignant Germ Cell Tumor of the Mediastinum Jpn. J. Clin. Oncol., July 1, 2004; 34(7): 386 - 392. [Abstract] [Full Text] [PDF]

				B. P. Schneider, K. A. Kesler, J. A. Brooks, C. Yiannoutsos, and L. H. Einhorn Outcome of Patients With Residual Germ Cell or Non-Germ Cell Malignancy After Resection of Primary Mediastinal Nonseminomatous Germ Cell Cancer J. Clin. Oncol., April 1, 2004; 22(7): 1195 - 1200. [Abstract] [Full Text] [PDF]

				C. Bokemeyer, C. R. Nichols, J.-P. Droz, H.-J. Schmoll, A. Horwich, A. Gerl, S. D. Fossa, J. Beyer, J. Pont, L. Kanz, et al. Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis J. Clin. Oncol., April 1, 2002; 20(7): 1864 - 1873. [Abstract] [Full Text] [PDF]

				J. T. Hartmann, L. Einhorn, C. R. Nichols, J.-P. Droz, A. Horwich, A. Gerl, S. D. Fossa, J. Beyer, J. Pont, H.-J. Schmoll, et al. Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis J. Clin. Oncol., March 15, 2001; 19(6): 1641 - 1648. [Abstract] [Full Text] [PDF]

				G. L. Walsh, G. D. Taylor, J. C. Nesbitt, and R. J. Amato Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors Ann. Thorac. Surg., February 1, 2000; 69(2): 337 - 343. [Abstract] [Full Text] [PDF]

				K. A. Kesler, K. M. Rieger, K. N. Ganjoo, M. Sharma, N. S. Fineberg, L. H. Einhorn, and J. W. Brown PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM CELL TUMORS: THE INFLUENCE OF POSTCHEMOTHERAPY PATHOLOGY ON LONG-TERM SURVIVAL AFTER SURGERY J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 692 - 701. [Abstract] [Full Text] [PDF]

				E. A. Bacha, A. R. Chapelier, P. Macchiarini, E. Fadel, and P. G. Dartevelle Surgery for invasive primary mediastinal tumors Ann. Thorac. Surg., July 1, 1998; 66(1): 234 - 239. [Abstract] [Full Text] [PDF]

				M. Rivoire, E. Voiglio, P. Kaemmerlen, I. Treilleux, P. Biron, and J. P. Droz SALVAGE RESECTION OF A CHEMOREFRACTORY MEDIASTINAL GERM CELL TUMOR J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1124 - 1126. [Full Text]

				T. Konishi, S. Fujino, Y. Chino, Y. Asada, S. Asakura, H. Kato, A. Mori, and H. Okabe Posterior mediastinal endodermal sinus (yolk sac) tumor in a female patient Ann. Thorac. Surg., July 1, 1994; 58(1): 244 - 245. [Abstract] [PDF]